title: Overexpression of CD3 eta during thymic development does not alter the negative selection process.
abstract: To elucidate the role of CD3 eta in thymic development and to determine whether CD3 eta is involved in the negative selection process, CD3 eta was overexpressed > 100 fold in transgenic (tg) mice using a Thy-1 promoter and regulatory elements. CD3 eta was readily observed in the majority of cortical thymocytes and in a fraction of medullary thymocytes in tg mice by immunohistochemical staining with an anti-CD3 eta-specific mAb. In contrast, endogenous CD3 eta levels were too low to detect in normal littermates. Flow cytometric analysis demonstrated an increased level of TCR on thymocytes with intermediate TCR density in tg animals and parallel biochemical studies showed a marked increased in TCR-associated CD3 zeta-eta heterodimers and CD3 eta-eta homodimers relative to controls. Despite this change in surface TCR phenotype, there was no significant alteration in the total numbers or proportion of CD4+CD8+ double-positive or CD4+CD8- or CD4-CD8+ single-positive thymocytes or peripheral T cells. Percentages of SP V beta 5, V beta 6, and V beta 8 thymocytes in tg animals were unaltered compared to normal littermates when backcrossed either to C57BL/6 (H-2b) or DBA/2 (H-2d) backgrounds. Furthermore, induction of DNA fragmentation with anti-CD3 epsilon mAb treatment in vivo was not significantly different for tg and normal littermates. Collectively, these data imply that CD3 eta is not a limiting component of the negative selection process.
authors.affiliation: Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115.
authors.forename: R E
authors.initials: RE
authors.lastname: Hussey
authors.forename: L K
authors.initials: LK
authors.lastname: Clayton
authors.forename: A
authors.initials: A
authors.lastname: Diener
authors.forename: D J
authors.initials: DJ
authors.lastname: McConkey
authors.forename: F D
authors.initials: FD
authors.lastname: Howard
authors.forename: H R
authors.initials: HR
authors.lastname: Rodewald
authors.forename: L
authors.initials: L
authors.lastname: D'Adamio
authors.forename: F
authors.initials: F
authors.lastname: Dallenbach
authors.forename: H
authors.initials: H
authors.lastname: Stein
authors.forename: E V
authors.initials: EV
authors.lastname: Schmidt
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000954:Antigens, Surface / Q000235:genetics; D001483:Base Sequence; D017252:CD3 Complex / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D016923:Cell Death; D002454:Cell Differentiation; D004249:DNA Damage; D005434:Flow Cytometry; D015870:Gene Expression; D015333:Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; D008562:Membrane Glycoproteins / Q000235:genetics; D051379:Mice; D008815:Mice, Inbred Strains; D008822:Mice, Transgenic; D008969:Molecular Sequence Data; D009838:Oligodeoxyribonucleotides / Q000737:chemistry; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000235:genetics; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics; D018800:Thy-1 Antigens; D013950:Thymus Gland / Q000166:cytology / Q000254:growth & development*
chemical_list: D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D017252:CD3 Complex; D008562:Membrane Glycoproteins; D009838:Oligodeoxyribonucleotides; D012333:RNA, Messenger; D016693:Receptors, Antigen, T-Cell, alpha-beta; D018800:Thy-1 Antigens